Study of the WE BEAT Online Well-Being Program for Teens with Moderate to Severe Congenital Heart Disease A Randomized Trial Comparing WE BEAT to Usual Care

What this Trial Is About

This research aims to evaluate if the WE BEAT program, a 5-week online group-based wellbeing and skill-building program, helps teens aged 12 to 17 with moderate to severe congenital heart disease CHD improve their ability to handle stress and become more resilient. The study compares participants who receive the WE BEAT program to those who receive usual care, looking at resilience and quality of life. It also explores connections between self-reported psychosocial data and clinical outcomes. Participants will be randomly assigned to either the WE BEAT telemedicine intervention or usual care. After completing the 5-week program, those in the intervention group will be further randomized to either receive a single booster session at week 18 or no booster session. The booster session reviews all skills introduced in the program. The study lasts about 6 months for all participants. During the study, participants complete four sets of online surveys and provide three hair or saliva samples at different times. Some may also give optional blood and urine samples. Researchers will measure resilience using the Connor-Davidson Resilience Scale and assess various psychosocial and biological markers related to stress and wellbeing. Safety and participant experience are monitored throughout the study period.

A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study